| Date Filed | Type | Description |
| 11/24/2021 |
4
| Prentiss Christopher B (CFO) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Granted 18,750 shares
@ $0
Unknown transaction of 163,767 shares
@ $0
Disposed/sold 37,500 options to buy
@ $6.81, valued at
$255.4k
Disposed/sold 50,000 options to buy
@ $4.7, valued at
$235k
|
|
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2020 |
4
| Prentiss Christopher B (CFO) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Sold 2,050 shares
@ $3.21, valued at
$6.6k
|
|
| 03/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2020 |
4
| Prentiss Christopher B (CFO) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Sold 1,269 shares
@ $5.92, valued at
$7.5k
|
|
| 11/08/2019 |
4
| Prentiss Christopher B (CFO) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Granted 25,000 shares
@ $0
Granted 50,000 options to buy
@ $4.7, valued at
$235k
|
|
| 07/23/2019 |
4
| Prentiss Christopher B (Chief Accounting Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Sold 1,082 shares
@ $6, valued at
$6.5k
|
|
| 04/10/2019 |
4
| Prentiss Christopher B (Chief Accounting Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Granted 18,750 shares
@ $0
Granted 37,500 options to buy
@ $6.81, valued at
$255.4k
|
|
| 03/21/2019 |
4
| Prentiss Christopher B (Chief Accounting Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Sold 1,185 shares
@ $8, valued at
$9.5k
|
|
| 12/28/2018 |
4
| Prentiss Christopher B (Chief Accounting Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Granted 12,500 shares
@ $0 |
|
| 12/26/2018 |
4
| Prentiss Christopher B (Chief Accounting Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Sold 228 shares
@ $7.51, valued at
$1.7k
|
|
| 03/22/2018 |
4
| Prentiss Christopher B (Chief Accounting Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Sold 567 shares
@ $25.98, valued at
$14.7k
|
|
| 03/09/2018 |
4
| Prentiss Christopher B (Chief Accounting Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Granted 5,000 shares
@ $0
Granted 30,000 options to buy
@ $25.66, valued at
$769.8k
|
|
| 10/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/22/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |